1. Home
  2. Labeler Index
  3. Ranbaxy Pharmaceuticals Inc.
  4. NDC Product Code: 63304-154 Benazepril Hydrochloride And Hydrochlorothiazide

NDC 63304-154 Benazepril Hydrochloride And Hydrochlorothiazide

View Dosage, Usage, Ingredients, Routes, UNII

Table of Contents

  1. Product Information
  2. Product Packages
  3. Product Characteristics
  4. What is NDC 63304-154?
  5. Benazepril Hydrochloride And Hydrochlorothiazide Uses
  6. Active Ingredients UNII Codes
  7. Inactive Ingredients UNII Codes
  8. NDC to RxNorm Crosswalk

Product Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.
NDC Product Code:
63304-154
Proprietary Name:
Benazepril Hydrochloride And Hydrochlorothiazide
Product Type: [3]
INACTIVATED PRODUCT and EXCLUDED the from NDC Directory
Labeler Name: [5]
Ranbaxy Pharmaceuticals Inc.
Labeler Code:
63304
Product Label ID:
1490589e-d0c9-4ae8-bce4-04eb09f55365
Start Marketing Date: [9]
04-10-2006
Listing Expiration Date: [11]
12-31-2019
Exclude Flag: [12]
I
Code Navigator:

Product Characteristics

Color(s):
WHITE (C48325)
Shape:
CAPSULE (C48336)
Size(s):
7 MM
Imprint(s):
RE15
Score:
2

Code Structure Chart

Product Details

What is NDC 63304-154?

The NDC code 63304-154 is assigned by the FDA to the product Benazepril Hydrochloride And Hydrochlorothiazide which is product labeled by Ranbaxy Pharmaceuticals Inc.. The product's dosage form is . The product is distributed in 3 packages with assigned NDC codes 63304-154-01 100 tablet, coated in 1 bottle , 63304-154-10 1000 tablet, coated in 1 bottle , 63304-154-30 30 tablet, coated in 1 bottle . This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

What are the uses for Benazepril Hydrochloride And Hydrochlorothiazide?

Benazepril hydrochloride and hydrochlorothiazide tablets are indicated for the treatment of hypertension. This fixed combination drug is not indicated for the initial therapy of hypertension (see DOSAGE AND ADMINISTRATION).

Which are Benazepril Hydrochloride And Hydrochlorothiazide UNII Codes?

The UNII codes for the active ingredients in this product are:

Which are Benazepril Hydrochloride And Hydrochlorothiazide Inactive Ingredients UNII Codes?

The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

What is the NDC to RxNorm Crosswalk for Benazepril Hydrochloride And Hydrochlorothiazide?

RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:
  • RxCUI: 898362 - benazepril HCl 10 MG / hydroCHLOROthiazide 12.5 MG Oral Tablet
  • RxCUI: 898362 - benazepril hydrochloride 10 MG / hydrochlorothiazide 12.5 MG Oral Tablet
  • RxCUI: 898362 - benazepril hydrochloride 10 MG / HCTZ 12.5 MG Oral Tablet
  • RxCUI: 898362 - BZP hydrochloride 10 MG / HCTZ 12.5 MG Oral Tablet
  • RxCUI: 898367 - benazepril HCl 20 MG / hydroCHLOROthiazide 12.5 MG Oral Tablet

* Please review the disclaimer below.

Product Footnotes

[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.

[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".